4-HYDROXY-4-(3-HYDROXY-1-BUTENYL)-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-ONE

Also known as: VOMIFOLIOL, 2-cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+)-, 2-cyclohexen-1-one, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-butenyl]-3,5,5-trimethyl, (4S)-, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-2-cyclohexen-1-one, (+)-, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-butenyl]-3,5,5-trimethyl-2-cyclohexen-1-one, (4S)-, 2-cyclohexen-1-one, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-, (4S)-, 4-hydroxy-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl-2-cyclohexen-1-one, (4S)-, roseoside aglycon, InChI=1S/C13H20O3/c1-9-7-11(15)8-12(3,4)13(9,16)6-5-10(2)14/h5-7,10,14,16H,8H2,1-4H3/b6-5+/t10-,13-/m1/s1, InChIKey: KPQMCAKZRXOZLB-KOIHBYQTSA-N

flavoring

United States (FDA)

GRAS

Technical function: FLAVORING AGENT OR ADJUVANT

CAS Number: 23526-45-6

4661; 24; 2058

European Union (EFSA)

EU regulatory status has not yet been reviewed for this additive. See the FDA inventory for US regulatory details.

Sources: FDA Substances Added to Food, EFSA opinions, EU Regulation 1333/2008, IARC monographs

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.